Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Medicated Skin Care in

Dermatologicals in the Netherlands

Oct 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Dermatologicals sees limited impacts from COVID-19 overall, as mature category typically follows historical patterns

Dermatologicals saw limited effects from COVID-19 in Q1 and Q2 2020. There was a small degree of stockpiling in Q1, for example with nappy (diaper) rash treatments as consumers feared a potential shortage, but this was much lower than other categories in consumer health.

Antipruritics sees boost as consumers treat dry and sore skin caused by excessive handwashing

Antipruritics shows the second strongest growth in 2020 and is a more significant category of note, as a higher number of consumers are turning to antipruritics to treat the skin of their hands which has become dry and sore from excessive handwashing due to COVID-19. Whilst this segment is also expected to return to more normal historical levels over time, antipruritics is seeing the greatest benefit from COVID-19.

GSK and Bayer show strong competition, as smaller player Remark wins shares by capitalising on the caterpillar plague with its specialist product

GSK Consumer Healthcare maintains a small lead on Bayer Consumer Care BV in company terms in dermatologicals in 2020. However, in brand terms, Bayer takes top place with its Canesten brand, with GSK’s Lamisil and Zovirax coming in second and third place.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Netherlands with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Netherlands, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Netherlands market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in Netherlands?
What are the major brands in Netherlands?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in the Netherlands - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Dermatologicals sees limited impacts from COVID-19 overall, as mature category typically follows historical patterns

Antipruritics sees boost as consumers treat dry and sore skin caused by excessive handwashing

GSK and Bayer show strong competition, as smaller player Remark wins shares by capitalising on the caterpillar plague with its specialist product

RECOVERY AND OPPORTUNITIES

Developments in antipruritics show best scope for ongoing progression during COVID-19 and beyond

Players offer portfolio diversification with less expensive, yet similar, products

Importance to identify sub-segments with lowered demand as a result of COVID-19

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2015-2020
Table 2 Sales of Dermatologicals by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals: % Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: % Value 2017-2020
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2017-2020
Table 6 Forecast Sales of Dermatologicals by Category: Value 2020-2025
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2020-2025

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 9 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2015-2020
Table 11 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 12 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 13 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
Table 15 Distribution of Consumer Health by Format: % Value 2015-2020
Table 16 Distribution of Consumer Health by Format and Category: % Value 2020
Table 17 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Megatrends

Country Report

Dermatologicals in the Netherlands

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Dermatologicals sees limited impacts from COVID-19 overall, as mature category typically follows historical patterns

Antipruritics sees boost as consumers treat dry and sore skin caused by excessive handwashing

GSK and Bayer show strong competition, as smaller player Remark wins shares by capitalising on the caterpillar plague with its specialist product

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in the Netherlands - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Dermatologicals sees limited impacts from COVID-19 overall, as mature category typically follows historical patterns

Antipruritics sees boost as consumers treat dry and sore skin caused by excessive handwashing

GSK and Bayer show strong competition, as smaller player Remark wins shares by capitalising on the caterpillar plague with its specialist product

RECOVERY AND OPPORTUNITIES

Developments in antipruritics show best scope for ongoing progression during COVID-19 and beyond

Players offer portfolio diversification with less expensive, yet similar, products

Importance to identify sub-segments with lowered demand as a result of COVID-19

CATEGORY DATA

Consumer Health in the Netherlands - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports